Castle Biosciences Inc $ 51.34 2.64 (5.42%)
Warning! GuruFocus has detected 1 Severe warning sign with CSTL. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for CSTL (Castle Biosciences Inc) from 2019 to Oct 22 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Castle Biosciences stock (CSTL) PE ratio as of Oct 22 2020 is 466.73. More Details
Castle Biosciences PE Ratio (TTM) Historical Data
View and export this data going back to 2019. Start your Free Trial
Castle Biosciences PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:QTNT NAS:VIVO NAS:HSKA NAS:PACB OTCPK:GWHP NAS:SRDX NAS:LNTH NAS:CODX NAS:AXDX NAS:RDNT NYSE:TMO NYSE:DHR NAS:ILMN XAMS:PHIA XSWX:LONN NAS:DXCM NYSE:IQV NYSE:A NAS:IDXX SHSE:603259
Traded in other countries CSTL.USA
Address 820 S. Friendswood Drive, Suite 201, Friendswood, TX, USA, 77546
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.